Skip to main content
UTHH-UTP Logo

Alert!

There has been an error in displaying this message. Please contact the site administrator.

News & Articles

UTHealth Houston Research

May 16, 2025

New study offers promising alternative to high-risk surgery for rare pregnancy complication

Written By: Laura Frnka-Davis | Updated: May 16, 2025
Leaving the placenta in place after childbirth may offer a safer alternative to immediate surgery for women with placenta accreta spectrum (PAS), according to a new study led by researchers at UTHealth Houston and published by the American College of Obstetricians and Gynecologists.
May 15, 2025

At the Bedside: Parents of daughters with rare Juvenile-onset Huntington’s disease find UTHealth Houston Center of Excellence for care and support

Written By: Deborah Mann Lake | Updated: May 15, 2025
In 2020, when she was 4 years old, Khloe Gloria stopped walking. At the suggestion of their local San Angelo physician, her concerned parents took her to see neurologists in Dallas. Khloe’s mom, Natalie Salazar, already had a sinking feeling she knew what the cause was.
May 12, 2025

UTHealth Houston study reveals long-term mental health benefits of healthy relationship skills program for adolescents

Written By: Jeannette Sanchez | Updated: May 12, 2025
Teaching healthy relationship skills to middle school students can help prevent adolescent relationship abuse and lead to better mental health outcomes — including reduced depression —  years later, according to researchers at UTHealth Houston.
April 17, 2025

Common genetic variants linked to drug-resistant epilepsy, according to research by UTHealth Houston and ULC

Written By: Media Relations | Updated: April 17, 2025
Certain common genetic changes might make some people with focal epilepsy less responsive to seizure medications, according to a new global study led by researchers from UCL in London and UTHealth Houston.
April 8, 2025

UTHealth Houston researchers investigate how proteins that help cells survive hypoxia might be used as therapy for heart and lung diseases

Written By: Laura Frnka-Davis | Updated: April 8, 2025
Scientists at UTHealth Houston are investigating how the body naturally adapts to hypoxia – an insufficient oxygen supply to the body or specific organs – to develop new treatments for life-threatening heart and lung diseases.
April 1, 2025

New perioperative institute launches to make surgery safer

Written By: Kenny Bybee | Updated: April 1, 2025
UTHealth Houston announced the establishment of the Institute of Perioperative Medicine, which will span different schools, including McGovern Medical School at UTHealth Houston and McWilliams School of Biomedical Informatics at UTHealth Houston.
March 24, 2025

Correcting imbalance with the gut microbiota after stroke could reduce brain inflammation, open pathway to potential therapies

Written By: Deborah Mann Lake | Updated: March 24, 2025
An imbalance in ligands, which are molecules produced by the body and the gut microbiota, can affect a key receptor protein that plays a role in brain inflammation after stroke, according to researchers at UTHealth Houston, who recently published their preclinical findings in Nature Communications.
March 14, 2025

Stem cell trial for early Alzheimer’s disease begins at UTHealth Houston

Written By: Deborah Mann Lake | Updated: March 14, 2025
A stem cell therapy trial aimed at reducing neuroinflammation in patients with presymptomatic Alzheimer’s disease is underway at UTHealth Houston.
March 13, 2025

UTHealth Houston among the nation’s best in research funding

Written By: Kenny Bybee | Updated: March 13, 2025
UTHealth Houston continues to rank among the nation’s top institutions for National Institutes of Health (NIH) research funding, according to the latest annual rankings from the Blue Ridge Institute for Medical Research.
February 12, 2025

New clinical trial at UTHealth Houston tests gene therapy vector that delivers drug aimed at stopping overactive bladder in patients with spinal cord injury

Written By: Deborah Mann Lake | Updated: February 12, 2025
A modified herpes virus that targets spinal cord nerve cells to treat neurogenic bladder in people with spinal cord injury is underway in a first-in-human clinical trial by UTHealth Houston at TIRR Memorial Hermann.

Categories

Categories
UTHH-UTP Logo

888-4UT-DOCS

888-488-3627

UTHealth Houston Professional Building

6410 Fannin Street
Houston, Texas 77030

QUICK LINKS
CAREERS
USA TODAY Top Work Places 2024

© Copyright 2024 – The University of Texas Health Science Center at Houston (UTHealth Houston)

Contact / Feedback | Report Error | Patient Privacy | Web File Viewing | Site Policies | Employee Links | Nondiscrimination Notice | Language Assistance Services

Facebook-f Instagram Linkedin Youtube Vimeo Flickr

Find a Doctor/Provider

Find Locations

Patient Care

Careers

Patient Info

Why UT Physicians